ArticlePloS one2023
A comprehensive framework for advanced protein classification and function prediction using synergistic approaches: Integrating bispectral analysis, machine learning, and deep learning.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated analysis of gene expressions and targeted mirnas for explaining crosstalk between oral and esophageal squamous cell carcinomas through an interpretable machine learning approach.Medical & biological engineering & computing · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proteins are fundamental components of diverse cellular systems and play crucial roles in a variety of disease processes. Consequently, it is crucial to comprehend their structure, function, and intricate interconnections. Classifying proteins into families or groups with comparable structural and functional characteristics is a crucial aspect of this comprehension. This classification is crucial for evolutionary research, predicting protein function, and identifying potential therapeutic targets. Sequence alignment and structure-based alignment are frequently ineffective techniques for identifying protein families.This study addresses the need for a more efficient and accurate technique for feature extraction and protein classification. The research proposes a novel method that integrates bispectrum characteristics, deep learning techniques, and machine learning algorithms to overcome the limitations of conventional methods. The proposed method uses numbers to represent protein sequences, utilizes bispectrum analysis, uses different topologies for convolutional neural networks to pull out features, and chooses robust features to classify protein families. The goal is to outperform existing methods for identifying protein families, thereby enhancing classification metrics. The materials consist of numerous protein datasets, whereas the methods incorporate bispectrum characteristics and deep learning strategies. The results of this study demonstrate that the proposed method for identifying protein families is superior to conventional approaches. Significantly enhanced quality metrics demonstrated the efficacy of the combined bispectrum and deep learning approaches. These findings have the potential to advance the field of protein biology and facilitate pharmaceutical innovation. In conclusion, this study presents a novel method that employs bispectrum characteristics and deep learning techniques to improve the precision and efficiency of protein family identification. The demonstrated advancements in classification metrics demonstrate this method's applicability to numerous scientific disciplines. This furthers our understanding of protein function and its implications for disease and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.